mpncancer

September 20, 2016
ropeginterferon

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Key points The novel IFNα-2b AOP2014 administered once every two weeks (or once a month) has low toxicity and induces high and sustained response rates in […]
August 30, 2016
Understanding the JAK2 mutation

Understanding the JAK2 Mutation

THE STORY OF JAK2 Four teams race to find the mysterious cause of a group of blood cancers. Click the link below for the complete article… […]
August 28, 2016
Frequency of MPN in Korea

Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea

J Korean Med Sci. 2016 Oct;31(10):1579-1585. English. Published online Jul 22, 2016.  http://dx.doi.org/10.3346/jkms.2016.31.10.1579 © 2016 The Korean Academy of Medical Sciences. Incidence, Survival and Prevalence Statistics of […]
August 16, 2016

Bone Marrow transplant without using chemo – Scientists create a safer way

Scientists have devised a way to destroy blood stem cells in mice without using chemotherapy or radiotherapy, both of which have toxic side effects. Blood stem […]
August 15, 2016
physical activity beneficial for MPNs

Physical Activity a Nonpharmacological Approach in Symptom Management in Myeloproliferative Neoplasms

Conclusions: MPN patients are understudied and there are currently no studies that have explored the effects of physical activity on sympton burden and QoL in these […]
August 13, 2016
T cells attacking blood cancer

New Treatment for Cancer may provide Hope to Incurable Patients

T cell Therapy shows promise fighting Blood Cancers Riddell’s preliminary findings on the success of T cell therapy to cure previously terminal cases of cancer made […]
Do NOT follow this link or you will be banned from the site!
Malcare WordPress Security